NCT02331706 2020-04-21
IFN-DLI for Relapsed Acute Leukemia After Allo-SCT
Abramson Cancer Center at Penn Medicine
Phase EARLY_PHASE1 Completed
Clinical Trials
3 trialsNCT00548847 2016-10-26
Immunotherapy for Acute Myeloid Leukemia (AML), Acute Lymphoblastic Leukemia (ALL), Blast Phase Chronic Myelogenous Leukemia (BP CML), and Myelodysplastic Syndrome (MDS) Relapse After Allogeneic Transplantation
Emory University
Phase 2 Completed
NCT00002621 2014-07-24
Interferon Alfa in Treating Children With HIV-Related Cancer
Children's Oncology Group
Phase 2 Completed